Conditions: Schizophrenia
Keywords: Acute schizophrenia PANSS
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 96
Healthy volunteers: no

Brief summary:
This is an 8-week, multi-centre, Open-label, non-comparative study to evaluate the efficacy and safety of Quetiapine XR with daily dose 400mg-800mg used as mono-therapy in the treatment of acute schizophrenic patients. The eligible patient will be assigned to study treatment with Quetiapine XR on Day 1.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Detailed description:

Arms:
arm 1: Seroquel XR 400-800mg

Interventions: intervention 1: Quetiapine Fumarate XR
Intervention descriptions: intervention 1: oral, once daily, flexible dose

Protocol document: